Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis

Kathleen Morrisroe; Wendy Stevens; Molla Huq; Joanne Sahhar; Gene-Siew Ngian; Jane Zochling; Janet Roddy; Susanna Proudman; Mandana Nikpour

Journal article

Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis

Kathleen Morrisroe, Wendy Stevens, Molla Huq, Joanne Sahhar, Gene-Siew Ngian, Jane Zochling, Janet Roddy, Susanna Proudman, Mandana Nikpour

Journal of Scleroderma and Related Disorders | WICHTIG PUBLISHING | Published : 2017

DOI: 10.5301/jsrd.5000243

University of Melbourne Researchers

Molla Huq Author Medicine - St Vincent's Hospital

Mandana Nikpour Author Medicine - St Vincent's Hospital

Related Projects (1)

Improving Outcomes In Systemic Autoimmune Disease: A Collaborative And Interdisciplinary Program Of Research

The multi-organ autoimmune diseases ‘scleroderma’ and ‘lupus’ have a profound negative impact on quality of life and life expectancy. The ov..

Grants

Awarded by NHMRC

Funding Acknowledgements

This work was supported by Scleroderma Australia, Arthritis Australia, Actelion Australia, Bayer, CSL Biotherapies, GlaxoSmithKline Australia and Pfizer. Dr. Morrisroe holds an NHMRC Scholarship (APP1113954). Dr. Nikpour holds an NHMRC Fellowship (APP1071735).